Literature DB >> 31757732

[Hypertension and contraception].

Sandrine Perol1, Justine Hugon-Rodin1, Geneviève Plu-Bureau2.   

Abstract

Hypertension is a major risk factor for cardiovascular diseases. Because of the high frequency of hormonal contraceptives use, assessing their side effects is an important public health issue. In this perspective, we conducted a review of the risk of hypertension associated with the use of hormonal contraceptives, either combined estrogen-progestin or only progestin. The use of combined hormonal contraceptives, regardless of its type and route of administration, is associated with a slight increase in blood pressure, both systolic and diastolic blood pressures. The frequency of onset of hypertension in women who use combined hormonal contraception is between 0.6% and 8.5%. Progestin-only contraception seems safe with respect to the risk of hypertension. It is therefore important to remember that the use of combined hormonal contraception is contra-indicated in hypertensive women, even well controlled. Finally, we propose a prescription assistance algorithm according to the recommendations of an expert panel. It should be remembered that taking blood pressure at each contraceptive consultation (initial and follow-up) is essential.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31757732     DOI: 10.1016/j.lpm.2019.07.033

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  2 in total

Review 1.  Combined Oral Contraceptive Pill-Induced Hypertension and Hypertensive Disorders of Pregnancy: Shared Mechanisms and Clinical Similarities.

Authors:  Madugodaralalage D S K Gunaratne; Bjorg Thorsteinsdottir; Vesna D Garovic
Journal:  Curr Hypertens Rep       Date:  2021-05-13       Impact factor: 5.369

2.  Hypertension in Children and Adolescents: A Position Statement From a Panel of Multidisciplinary Experts Coordinated by the French Society of Hypertension.

Authors:  Béatrice Bouhanick; Philippe Sosner; Karine Brochard; Claire Mounier-Véhier; Geneviève Plu-Bureau; Sébastien Hascoet; Bruno Ranchin; Christine Pietrement; Laetitia Martinerie; Jean Marc Boivin; Jean Pierre Fauvel; Justine Bacchetta
Journal:  Front Pediatr       Date:  2021-07-07       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.